Collegium Pharmaceutical, Inc. (COLL)
27.39
+0.28
(+1.02%)
USD |
NASDAQ |
Aug 24, 16:00
27.39
0.00 (0.00%)
After-Hours: 20:00
Collegium Pharmaceutical Shareholders Equity (Quarterly) : 311.91M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 311.91M |
| March 31, 2026 | 312.42M |
| December 31, 2025 | 301.68M |
| September 30, 2025 | 274.81M |
| June 30, 2025 | 232.21M |
| March 31, 2025 | 234.43M |
| December 31, 2024 | 228.84M |
| September 30, 2024 | 234.28M |
| June 30, 2024 | 216.58M |
| March 31, 2024 | 222.17M |
| December 31, 2023 | 195.43M |
| September 30, 2023 | 178.87M |
| June 30, 2023 | 200.80M |
| March 31, 2023 | 179.73M |
| December 31, 2022 | 194.84M |
| September 30, 2022 | 197.19M |
| June 30, 2022 | 197.61M |
| March 31, 2022 | 196.08M |
| December 31, 2021 | 202.93M |
| September 30, 2021 | 251.09M |
| June 30, 2021 | 253.07M |
| March 31, 2021 | 170.04M |
| December 31, 2020 | 186.03M |
| Date | Value |
|---|---|
| September 30, 2020 | 172.69M |
| June 30, 2020 | 155.77M |
| March 31, 2020 | 141.06M |
| December 31, 2019 | 87.43M |
| September 30, 2019 | 84.26M |
| June 30, 2019 | 85.82M |
| March 31, 2019 | 86.35M |
| December 31, 2018 | 91.58M |
| September 30, 2018 | 70.78M |
| June 30, 2018 | 82.68M |
| March 31, 2018 | 90.82M |
| December 31, 2017 | 104.08M |
| September 30, 2017 | 96.27M |
| June 30, 2017 | 95.51M |
| March 31, 2017 | 114.37M |
| December 31, 2016 | 134.91M |
| September 30, 2016 | 74.32M |
| June 30, 2016 | 98.66M |
| March 31, 2016 | 121.74M |
| December 31, 2015 | 85.07M |
| September 30, 2015 | 93.56M |
| June 30, 2015 | 102.42M |
| March 31, 2015 | 34.45M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Innoviva, Inc. | 1.233B |
| Zevra Therapeutics, Inc. | 217.65M |
| Supernus Pharmaceuticals, Inc. | 1.031B |
| Indivior Pharmaceuticals, Inc. | -208.00M |
| Crinetics Pharmaceuticals, Inc. | 1.192B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.136B |
| Total Liabilities (Quarterly) | 1.824B |
| Debt to Equity Ratio | 3.905 |
| Current Ratio | 1.031 |
| Net Debt Paydown Yield | -4.29% |